The pharmaceutical industry wants to counteract its image as cost drivers. „We are capable of doing more than just charging prices for medicinal products“, Hagen Pfunder, head of the Association of Pharmaceutical Research Companies (VFA), emphasized at the association’s general meeting. He stressed the contributions of the pharmaceutical companies to the economic development in Germany.
Pfundner’s vision for the pharmaceutical industry is that they must be able to contribute to the service landscape without being accused of being greedy. A major problem is the concern of doctors regarding their freedom of prescription whenever a pharmaceutical company joins an integrated health care model.
Pfunder wishes for politicians who advance new co-operations between doctors, insurers, science and industry rather than automatically challenging them.
[ilink url=“http://www.aerztezeitung.de/politik_gesellschaft/arzneimittelpolitik/article/827212/gesundheit-vs-imageproblem-pharmaindustrie-draengt-versorgung.html“] Link to source (Ärzte Zeitung)[/ilink]